Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1959 2
1963 1
1965 1
1968 1
1973 1
1974 1
1976 1
1977 1
1978 4
1979 2
1980 2
1981 1
1982 2
1983 5
1984 9
1985 7
1986 3
1987 4
1988 3
1989 5
1990 4
1991 3
1992 2
1993 11
1994 11
1995 7
1996 10
1997 7
1998 9
1999 14
2000 9
2001 13
2002 21
2003 19
2004 28
2005 29
2006 50
2007 55
2008 60
2009 46
2010 86
2011 101
2012 112
2013 120
2014 143
2015 173
2016 165
2017 190
2018 194
2019 208
2020 248
2021 324
2022 208
Text availability
Article attribute
Article type
Publication date

Search Results

2,446 results
Results by year
Filters applied: . Clear all
Page 1
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, Boehnke K, Lynch KN, Xu R, Zarrella DT, Gu S, Cejas P, Lim K, Long HW, Elias KM, Horowitz NS, Feltmate CM, Muto MG, Worley MJ Jr, Berkowitz RS, Matulonis UA, Nucci MR, Crum CP, Rueda BR, Brown M, Liu XS, Hill SJ. Wan C, et al. Cancer Res. 2021 Jan 1;81(1):158-173. doi: 10.1158/0008-5472.CAN-20-1674. Epub 2020 Nov 6. Cancer Res. 2021. PMID: 33158814 Free PMC article.
Pyroptosis in the Initiation and Progression of Atherosclerosis.
Qian Z, Zhao Y, Wan C, Deng Y, Zhuang Y, Xu Y, Zhu Y, Lu S, Bao Z. Qian Z, et al. Among authors: wan c. Front Pharmacol. 2021 May 26;12:652963. doi: 10.3389/fphar.2021.652963. eCollection 2021. Front Pharmacol. 2021. PMID: 34122076 Free PMC article. Review.
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.
Fang Y, Wang L, Wan C, Sun Y, Van der Jeught K, Zhou Z, Dong T, So KM, Yu T, Li Y, Eyvani H, Colter AB, Dong E, Cao S, Wang J, Schneider BP, Sandusky GE, Liu Y, Zhang C, Lu X, Zhang X. Fang Y, et al. Among authors: wan c. J Clin Invest. 2021 Jan 4;131(1):e140837. doi: 10.1172/JCI140837. J Clin Invest. 2021. PMID: 32990678 Free PMC article.
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X. Xu H, et al. Among authors: wan c. J Clin Invest. 2021 May 17;131(10):e146832. doi: 10.1172/JCI146832. J Clin Invest. 2021. PMID: 33830945 Free PMC article.
2,446 results